Skip to main content

Table 1 30-day point prevalent abstinence at 6 months and 12 months by treatment group

From: Simultaneous vs. sequential treatment for smoking and weight management in tobacco quitlines: 6 and 12 month outcomes from a randomized trial

 

Control N = 840

Sequential N = 849

Simultaneous N = 839

Weight management treatment vs control: Wald’s X2; p-value

6-month outcomes

 % abstinent (Multiply Imputed)

44.9

48.3

40.3

2.94; p = 0.08a

 % abstinent (Missing = Smoking)

24.4

23.8

19.2

7.84; p = 0.02b

12-month outcomes

 % abstinent (Multiply Imputed)

46.0

46.3

40.7

1.83, p = 0.16c

 % abstinent (Missing = Smoking)

28.2

26.9

24.1

3.89, p = 0.14

  1. aThere was a statistically significant difference between the simultaneous and control groups (p = 0.036) and between simultaneous and sequential (p = 0.032).
  2. bThere was a statistically significant difference between the simultaneous and sequential groups (p = 0.024) and between the simultaneous and control groups (p = 0.01).
  3. cSimultaneous group was significantly different from controls (p = 0.039)